These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11782300)
21. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction]. Xu B; Yao G Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813 [TBL] [Abstract][Full Text] [Related]
22. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [TBL] [Abstract][Full Text] [Related]
23. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis]. Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus DNA in patients with HBsAg in south western Nigeria. Odaibo GN; Ola SO; Olaleye OD J Med Virol; 2013 Feb; 85(2):214-8. PubMed ID: 23161583 [TBL] [Abstract][Full Text] [Related]
25. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases. Jelić D; Jelić O Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502 [TBL] [Abstract][Full Text] [Related]
26. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B. Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659 [TBL] [Abstract][Full Text] [Related]
28. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901 [TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666 [TBL] [Abstract][Full Text] [Related]
30. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India. Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826 [TBL] [Abstract][Full Text] [Related]
31. HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy. Rapicetta M; di Nardo V; Rozera C; Marinucci G; Francisci D; Sarrecchia B; Ricci C; Albertoni F Epidemiol Infect; 1990 Jun; 104(3):511-7. PubMed ID: 2347388 [TBL] [Abstract][Full Text] [Related]
33. [The contrast study of Pre-S1 protein, HBV-DNA and HBeAg in diagnosing viral replication in patients with chronic hepatitis B]. Li Q; Sun GZ; Wei YX; Min YY; Cong YL; Ou XJ; Wang BE Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):134-6. PubMed ID: 15059293 [TBL] [Abstract][Full Text] [Related]
34. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume. Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025 [TBL] [Abstract][Full Text] [Related]
35. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood. Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948 [TBL] [Abstract][Full Text] [Related]
36. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237 [TBL] [Abstract][Full Text] [Related]
38. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers. Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353 [TBL] [Abstract][Full Text] [Related]
39. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514 [TBL] [Abstract][Full Text] [Related]
40. Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies. Lai MY; Chen DS; Lee SC; Su IJ; Yang PM; Hsu HC; Sung JL Hepatogastroenterology; 1988 Feb; 35(1):17-21. PubMed ID: 3360397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]